RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Thyroid Gland Disorders - Pipeline Review, Q2 2011
May 2011 - 23 pages - $500
Thyroid Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Apr 2011 - 78 pages - $2,000
Thyroid Cancer - Pipeline Review, Q4 2010
Dec 2010 - 46 pages - $500
Medullary Thyroid Cancer Global Clinical Trials Review, Q1, 2011
Jan 2011 - 28 pages - $1,000
Tercica Inc: Premium Company Profile
Dec 2007 - 56 pages - $495
Medullary Thyroid Cancer - Pipeline Review, Q1 2011
Jan 2011 - 26 pages - $500
Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine Tumors and Thyroid Cancer - New drug approvals likely after decades of little progress
Dec 2010 - 269 pages - $11,400
Growth Disorders - Pipeline Review, Q1 2011
Feb 2011 - 36 pages - $500
Thyroid Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 63 pages - $1,000
Medullary Thyroid Cancer - Pipeline Review, Q3 2011
Jul 2011 - 41 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Clinical research del
Therapeutic target
Endocrinology del
Thyroid disorders del
Year
2002 del

Browse By

Therapeutic target
Hyperparathyroidism
Hyperthyroidism
Hypothyroidism

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us